scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH
· Real-Time Price · USD
4.60
-0.35 (-7.07%)
At close: Aug 15, 2025, 3:59 PM
4.60
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
scPharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 49.97M | 41.98M | 36.33M | 30.28M | 24.05M | 17.63M | 13.59M | 7.5M | 3.7M | 2.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 15.76M | 13.05M | 11.41M | 9.22M | 6.99M | 5.04M | 3.81M | 2.16M | 1.2M | 971K | 468K | 459K | 453K | 434K | 438K | 327K | 215K | 106K |
Gross Profit | 34.21M | 28.93M | 24.92M | 21.06M | 17.06M | 12.59M | 9.78M | 5.34M | 2.5M | 1.09M | -468K | -459K | -453K | -434K | -438K | -327K | -215K | -106K |
Operating Income | -66.54M | -66.68M | -64.78M | -63.69M | -60.38M | -59.7M | -55.4M | -49.64M | -44.8M | -40.47M | -36.16M | -33.38M | -29.29M | -26.32M | -25.82M | -26.27M | -28.8M | -30.02M |
Interest Income | 3.13M | 3.28M | 3.44M | 3.57M | 3.97M | 4.67M | 5.1M | 4.83M | 3.76M | 2.5M | 1.2M | 359K | 137K | 42K | 49K | 76K | 102K | 111K |
Pretax Income | -91.72M | -90.78M | -85.15M | -80.11M | -60.64M | -57.71M | -54.81M | -50.25M | -44.77M | -40.32M | -36.84M | -34.91M | -31.3M | -28.66M | -28.03M | -28.5M | -30.99M | -32.22M |
Net Income | -91.72M | -90.78M | -85.15M | -80.11M | -60.64M | -57.71M | -56.43M | -52.38M | -47.07M | -42.89M | -38.29M | -35.84M | -32.06M | -29.15M | -28.03M | -28.5M | -30.99M | -32.22M |
Selling & General & Admin | 85.33M | 81.61M | 77.6M | 72.47M | 65.28M | 59.87M | 53.37M | 44.3M | 36.45M | 28.63M | 20.63M | 15.64M | 11.57M | 9.94M | 9.78M | 11.02M | 12.13M | 12.01M |
Research & Development | 15.42M | 14M | 12.1M | 12.28M | 12.16M | 12.42M | 11.81M | 10.8M | 11.09M | 13.3M | 15.53M | 17.74M | 17.71M | 16.38M | 16.04M | 15.26M | 16.68M | 18.01M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.36M | 1.34M | 1.41M | 1.42M | 73K | 105K | 74K | 315K | 307K | 316K | 282K |
Operating Expenses | 100.75M | 95.61M | 89.7M | 84.75M | 77.44M | 72.29M | 65.18M | 55.1M | 47.54M | 41.93M | 36.16M | 33.38M | 29.29M | 26.32M | 25.82M | 26.27M | 28.8M | 30.02M |
Interest Expense | 3.35M | 4.08M | 7.57M | 8.18M | 8.39M | 8.26M | 8.12M | 7.99M | 6.31M | 4.74M | 3.3M | 1.96M | 2.25M | 2.46M | 2.58M | 2.61M | 2.6M | 2.59M |
Selling & Marketing Expenses | n/a | n/a | 16.32M | 9.57M | 9.57M | 9.57M | -6.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 116.51M | 108.66M | 101.11M | 93.97M | 84.43M | 77.33M | 68.99M | 57.14M | 48.5M | 42.53M | 36.16M | 33.38M | 29.29M | 26.32M | 25.82M | 26.27M | 28.8M | 30.02M |
Income Tax Expense | -7.72K | -7.72K | -7.72K | n/a | n/a | n/a | 1.62M | 2.13M | 2.3M | 2.57M | 1.45M | 934K | 767K | 491K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 53.72M | 53.68M | 44.52M | 46.56M | 38.98M | 38.95M | 38.79M | 38.76M | 38.69M | 37.8M | 31.25M | 27.4M | 27.38M | 27.37M | 27.36M | 27.3M | 27.16M | 27.34M |
Shares Outstanding (Diluted) | 53.72M | 53.68M | 44.52M | 46.56M | 38.98M | 38.95M | 38.79M | 38.76M | 38.69M | 37.8M | 31.25M | 27.4M | 27.38M | 27.37M | 27.36M | 27.36M | 27.36M | 27.34M |
EPS (Basic) | -1.88 | -1.98 | -1.97 | -1.91 | -1.56 | -1.49 | -1.47 | -1.42 | -1.4 | -1.39 | -1.35 | -1.31 | -1.17 | -1.07 | -1.03 | -1.04 | -1.13 | -1.23 |
EPS (Diluted) | -1.88 | -1.98 | -1.97 | -1.91 | -1.56 | -1.49 | -1.47 | -1.42 | -1.4 | -1.39 | -1.35 | -1.31 | -1.17 | -1.07 | -1.03 | -1.04 | -1.13 | -1.23 |
EBITDA | -82.6M | -83.21M | -77.41M | -71.69M | -51.74M | -48.87M | -46.06M | -41.65M | -38.02M | -35.1M | -33.07M | -32.49M | -28.59M | -25.77M | -25.02M | -25.46M | -27.97M | -29.22M |
EBIT | -85.59M | -83.93M | -77.58M | -71.94M | -52.26M | -49.45M | -46.69M | -42.26M | -38.47M | -35.57M | -33.54M | -32.95M | -29.05M | -26.21M | -25.46M | -25.89M | -28.39M | -29.63M |
Depreciation & Amortization | 24K | 12K | n/a | 156K | 515K | 572K | 626K | 606K | 452K | 471K | 468K | 459K | 453K | 434K | 438K | 431K | 420K | 410K |